Lexaria Bioscience Corp Forecast, price target & analysts
Lexaria Bioscience Corp Target price 2025 - Analyst rating & recommendation
Lexaria Bioscience Corp Classifications & Recommendation:
Lexaria Bioscience Corp Price Target
| Target Price | $6.12 |
| Price | $1.12 |
| Potential |
446.43%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Lexaria Bioscience Corp 2026 .
The average Lexaria Bioscience Corp target price is $6.12.
This is
446.43%
register free of charge
$6.30
462.50%
register free of charge
$4.04
260.71%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Lexaria Bioscience Corp to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lexaria Bioscience Corp stock has an average upside potential 2026 of
446.43%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Aug '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.46 | 0.68 |
| 100.00% | 48.35% | |
| Net Margin | -1,260.87% | -1,968.31% |
| 56.46% | 56.11% |
5 Analysts have issued a sales forecast Lexaria Bioscience Corp 2025 . The average Lexaria Bioscience Corp sales estimate is
This results in the following potential growth metrics:
5 Lexaria Bioscience Corp Analysts have issued a net profit forecast 2025. The average Lexaria Bioscience Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Aug '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.47 | -0.69 |
| 53.47% | 46.81% | |
| P/E | negative | |
| EV/Sales | 29.69 |
5 Analysts have issued a Lexaria Bioscience Corp forecast for earnings per share. The average Lexaria Bioscience Corp EPS is
This results in the following potential growth metrics and future valuations:
Lexaria Bioscience Corp...
Current Lexaria Bioscience Corp Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 29 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 25 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 29 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 02 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 25 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
